Market Access News | pharmaphorum

News

Kerendia pill bottle with tablets on surface

Bayer files finerenone in EU for heart failure

Bayer has filed its mineralocorticoid receptor antagonist finerenone as a treatment heart failure in the EU, but can it meet blockbuster sales hopes?

News

Woman in protective clothing in a laboratory

Report says AZ's UK plant decision is not just about funding

It's been reported that the UK government made an offer of £78 million in funding for AstraZeneca's abandoned £450 million vaccine facility in Speke.

News

Boost to Enhertu's prospects as FDA clears Roche diagnostic

Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.

News

CHMP backs Bavarian Nordic's chikungunya jab

Bavarian Nordic is likely just weeks away from bringing the second chikungunya vaccine to the EU, and the first approved for use in adolescents.

News

AstraZeneca abandons plan for £450m vaccine plant in UK

In a shock move, AstraZeneca has ditched its plan to invest £450m in a new vaccine manufacturing plant in the UK.

News

EMA experts will look again at Leqembi's safety data

It seems Eisai and Biogen have another hurdle to jump over in their bid to get EU approval for their Alzheimer's disease therapy Leqembi.

Bayer files finerenone in EU for heart failure

Report says AZ's UK plant decision is not just about funding

Boost to Enhertu's prospects as FDA clears Roche diagnostic

CHMP backs Bavarian Nordic's chikungunya jab

AstraZeneca abandons plan for £450m vaccine plant in UK

EMA experts will look again at Leqembi's safety data

Amgen's Imdelltra scores again in small cell lung cancer

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks